Histopathologic features of selumetinib‐induced paronychia in a child with neurofibromatosis type 1

• Ngā kaituhi matua: P. Borgia (Author), J. Ferro (Author), G. Piccolo (Author), P. Striano (Author), V. G. Vellone (Author), G. Viglizzo (Author), M. C. Diana (Author)
• Hōputu: Pukapuka
• I whakaputaina: Wiley, 2024-06-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

Abstract We report a 4‐year‐old girl developing therapy refractory paronychia induced by selumetinib, an oral selective inhibitor of mitogen‐activated protein kinase 1/2 prescribed for a large submandibular plexiform neurofibroma. Although this cutaneous reaction is well‐known and more prevalent in...